Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Found vs VivioMD

By GLP-1 ScorecardUpdated

FoundFactor scores not reassessed.
Site position #7

Higher score

VivioMDFactor scores not reassessed.
Site position #433

Lower score

Score comparison

Found has the higher recorded score — 83.5/100 to 57.4/100.

Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.

Before you choose

VivioMD does not publish a semaglutide price, so its VivioMD review sets out what it does disclose, while the Found review explains the conditions attached to Found's figure. The semaglutide cost page compares published rates across the field. Ask VivioMD for a written total before treating either one as the cheaper choice.

If neither one fits, Found vs Walgreens Weight Management and Gala Health vs VivioMD compare each of them with another graded program, and the list of alternatives to Found ranks the programs closest to Found on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueFound +33
78
45
Dose & formulationFound +18
94
76
Clinical oversightFound +31
86
55
Labs & monitoringFound +29
82
53
FulfillmentFound +3
84
81
Contract termsFound +41
70
29
Found · top barVivioMD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricFoundVivioMD
WeighScore83.5/10057.4/100
GradeBC
Site position#7#433
Semaglutide$149 first, then $269 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)Not disclosed
Tirzepatide$199 first, then $339 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)Not disclosed
CoverageU.S. service with state, treatment and insurance restrictions; confirm your eligibilityTerms exclude Louisiana; homepage advertises providers in all 50 states
Brand-name accessYesYes
Oral / sublingualYesNot confirmed
Found

Site position #7 · B

Factor scores not reassessed.

Strengths

  • Current compounded offers include medication, membership and care, with separate semaglutide and tirzepatide price tables
  • Branded injection and oral options are listed, subject to prescription, stock and patient-specific terms
  • Insurance-track clinical visits and cash-pay care are distinguished in the public billing documents
  • Terms name possible independent medical groups and describe check-ins and messaging

What to consider

  • Cash compounded renewal rates differ by molecule and recur every 28 days, not a calendar month
  • Longer-term advertised rates and upfront-payment wording do not settle the selected charge or supply
  • Labs cost extra; insurance-track cost-sharing can add to the bill and does not reimburse compounded-medication fees
  • Refund wording about three days and the first consultation conflicts; rejection of a preferred GLP-1 is not disqualification from all treatment
  • The assigned compounder, actual treating practice and individual license status remain unresolved
  • A brand or oral menu listing does not establish a specific available prescription, complete price or clinical equivalence
VivioMD

Site position #433 · C

Factor scores not reassessed.

FDAWarning letter issued to VivioMD Group LLC dba VivioMD in June 2026. See the FDA warning-letter database.

Strengths

  • Terms identify OpenLoop clinical groups and list RedRock, Health Warehouse and Triad Rx
  • Public refund policy states the renewal cancellation cutoff

What to consider

  • Reviewed homepage does not show drug-specific pricing
  • Terms exclude Louisiana despite nationwide provider language
  • Cancellation requests must arrive at least 72 hours before the next bill
  • Compounded medications are not FDA-approved

Featured provider

Found

Factor scores not reassessed.

Found scores 83.5/100 (B). Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard